Sold by: OneMedNet Corporation
Deployed on AWS
For this Lung Cancer dataset,four distinct cohorts have been prepared including (1) patients with confirmed nodules (2) patients with confirmed nodules and malignancy (3) patients with confirmed nodules and confounders (4) normal (negative results) for control group.
Overview
For this Lung Cancer dataset,four distinct cohorts have been prepared including (1) patients with confirmed nodules (2) patients with confirmed nodules and malignancy (3) patients with confirmed nodules and confounders (4) normal (negative results) for control group.
Each patient study includes both the computed radiography (CR) as well as the follow-up corresponding computed tomography (CT) on confirmed positive. CT is full Lung Series and have optimal slice thickness of <= 3 mm.
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,400 healthcare sites through its iRWD platform. This isn't just data, its the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
We are providing a free sample from each cohort. If you require additional data or data enrichment or have any questions, please contact us directly at sales@onemednet.com .
Details
Sold by
Categories
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Vendor refund policy
Refunds are not available for this offer.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
Oncology - Lung Cancer - CXR+CT - Nodule and Cancer | Last 1 revisions | No future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
Open-source NER model for cancer genetics entities in biomedical and clinical text. Trained on BioNLP2013-CG and optimized for state-of-the-art precision, it enables reliable extraction with fast, easy deployment via Hugging Face Transformers.
Open-source NER model for cancer genetics entities in biomedical and clinical text. Trained on BioNLP2013-CG and optimized for state-of-the-art precision, it enables reliable extraction with fast, easy deployment via Hugging Face Transformers.
Open-source NER model for cancer genetics entities in biomedical and clinical text. Trained on BioNLP2013-CG and optimized for state-of-the-art precision, it enables reliable extraction with fast, easy deployment via Hugging Face Transformers.
High-quality de-identified EHR data, showcasing comprehensive patient journeys and physician narratives in Dermatology. This data provides a comprehensive picture of the patient's journey and physician narrative throughout their hospital stay. With approximately 4 million+ unique patient records, the participating hospitals offer unique insights into variations in care across healthcare network hospitals and clinics. All sample data is de-identified and does not contain PHI.
Examine medication consumption patterns in granular, down to the hour, details of self-reported and de-identified patients taking Oncology- Neutropenia Inhibitors in combination with additional medications to gain insight about specific behaviors.